Also trades as: RGBPP (OTC) · $vol 0M
RGBP OTC
Regen BioPharma, Inc.
1W: +40.0%
1M: +13900.0%
3M: +40.0%
YTD: -98.4%
1Y: -98.9%
3Y: -100.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Weekly Expected Move ±8730.1%
$-0
$-0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.00005-0.035
Volume655,000
Avg Volume25,629,550
Beta0.23
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEODavid Raymond Koos
Employees1
SectorHealthcare
IndustryBiotechnology
IPO Date2014-10-06
Websiteregenbiopharmainc.com
8697 La Mesa Boulevard
La Mesa, CA 91942
US
La Mesa, CA 91942
US
619 722 5505
About Regen BioPharma, Inc.
Regen BioPharma, Inc. is a company dedicated to advancing regenerative medicine within the United States. It actively researches and identifies small molecule compounds designed to modulate the NR2F6 gene. This modulation is strategically aimed at activating immune cells for oncology treatments and suppressing them for autoimmune conditions. Its therapeutic pipeline and product development are currently in their initial phases. Established in 2012, the firm operates from its headquarters in La Mesa, California.
Latest News
No recent news
Recent Insider Trades
No insider trades found